相关实验视频

Updated: Feb 27, 2026

Identification and Protection of the Recurrent Laryngeal Nerve during Transoral Robotic Thyroidectomy

Identification and Protection of the Recurrent Laryngeal Nerve during Transoral Robotic Thyroidectomy

Published on: October 24, 2025

术前甲状腺激素敏感性状况对于皮肤状甲状腺癌复发的预后意义

Canxiao Li¹, Shijie Li¹, Yishen Zhao¹

¹Division of Thyroid Surgery, The China-Japan Union Hospital of Jilin University, Jilin Provincial Key Laboratory of Thyroid Disease, Jilin Provincial Precision Medicine Laboratory of Molecular Biology and Translational Medicine on Differentiated Thyroid Carcinoma, Changchun City, Jilin Province, China.

|February 25, 2026

概括

甲状腺激素耐药性,以高甲状腺激素指数 (TSHI) 和甲状腺激素T4耐药性指数 (TT4RI) 表示,是预防乳头甲状腺癌 (PTC) 复发的保护因素. 这些指数显著改善了复发预测,特别是当它们结合在一起时.

科学领域:

内分泌学在内分泌学.
在瘤学瘤学.
分子生物学分子生物学

背景情况:

甲状腺激素敏感性和乳头甲状腺癌 (PTC) 患者的复发风险之间的关联尚未得到充分理解.
诸如TSH抑制效率和自身免疫机制等因素可能会影响这种关系.

研究的目的:

研究甲状腺激素敏感性指数之间的相互关系.
评估它们作为预测PTC复发的生物标志物的有用性.

主要方法:

对2015年1月至2016年7月期间诊断的196名PTC患者的回顾性分析.
后勤回归分析,以评估甲状腺增生蛋白指数 (TSHI) 和甲状腺增生蛋白T4抵抗指数 (TT4RI) 与PTC复发的关联.

主要成果:

升高的TSHI (≥3.6) 和TT4RI (≥54.2) 独立地与降低PTC复发风险相关 (P<0.05).
包括这些指数显著提高了复发预测准确度 (P<0.001).
TSHI和TT4RI的组合显示出优异的预测性能 (AUC=0.790,P<0.001).

结论:

甲状腺激素耐药性,以高的TSHI和TT4RI表示,是防止PTC复发的保护因素.
这些指数共同提高复发预测,并可以优化术后监测策略PTC患者.

关键词:

乳头甲状腺癌是一种乳头甲状腺癌.预测生物标志物预测生物标志物复发情况复发情况风险评估风险评估风险评估甲状腺激素敏感度指数

更多相关视频

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter

Published on: September 20, 2024

相关概念视频

Synthesis and Regulation of Thyroid Hormones

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...